Analysis of tumor-infiltrating exhausted T cells highlights IL-6 and PD1 blockade as a combined immunotherapy strategy for non-small cell lung cancerLulu Zhang, Qing Yuan, Yingchun Ye et al.|Frontiers in Immunology|2025Cited by 12
Interleukin 8 in plasma is an efficacy marker for advanced non-small cell lung cancer treated with hypofractionated radiotherapy and PD-1 blockadePengyuan Kang, Qing Yuan, Dan Liu et al.|Cytokine|2023Cited by 10